Loading...
BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML?
Nearly four decades after their conceptualization, antibody-based therapies are slowly being added to the treatment landscape of acute myeloid leukemia (AML). While the antibody–drug conjugate gemtuzumab ozogamicin is the only antibody-based therapy that has been approved for AML treatment thus far,...
Saved in:
| Published in: | Life (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8224808/ https://ncbi.nlm.nih.gov/pubmed/34071099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11060465 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|